Also trades as: NGLFINE.NS (NSE) · $vol 1M
NGLFINE.BO BSE
NGL Fine-Chem Limited
1W: +1.0%
1M: +8.9%
3M: -10.2%
YTD: +31.2%
1Y: +118.6%
3Y: +51.4%
₹2,905.00 ($30.18)
-20.50 (-0.70%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$5.5B
+25.9% ▲
5Y CAGR: +21.3%
Total Liabilities
$2.2B
+43.3% ▲
5Y CAGR: +32.3%
Shareholders Equity
$3.3B
+16.6% ▲
5Y CAGR: +16.3%
Cash & Investments
$443M
-32.4% ▼
5Y CAGR: +5.5%
Total Debt
$1.1B
+48.3% ▲
5Y CAGR: +45.8%
Net Debt
$1.1B
+57.1% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $6M | $78M | $4M | $59M | $28M |
| Short-Term Investments | $289M | $447M | $549M | $597M | $415M |
| Cash & ST Investments | $295M | $525M | $553M | $655M | $443M |
| Net Receivables | $640M | $659M | $896M | $816M | $1.5B |
| Inventory | $560M | $270M | $433M | $513M | $703M |
| Other Current Assets | $226M | $156M | $226M | $370M | $81M |
| Total Current Assets | $1.7B | $1.6B | $2.1B | $2.4B | $2.8B |
| Property, Plant & Equip. | $947M | $1.1B | $1.3B | $1.9B | $2.6B |
| Goodwill & Intangibles | $5M | $3M | $3M | $5M | $4M |
| Long-Term Investments | $26M | $44M | $46M | $10M | $52M |
| Other Non-Current Assets | $3K | $14M | $72M | $46M | $50M |
| Total Non-Current Assets | $1.0B | $1.2B | $1.4B | $2.0B | $2.7B |
| Total Assets | $2.8B | $2.9B | $3.6B | $4.3B | $5.5B |
| — Liabilities — | |||||
| Accounts Payable | $372M | $246M | $494M | $575M | $646M |
| Short-Term Debt | $266M | $304M | $333M | $478M | $521M |
| Deferred Revenue | $19M | $53M | $0 | $0 | $0 |
| Other Current Liabilities | -$5M | -$26M | $33M | $136M | $313M |
| Total Current Liabilities | $657M | $583M | $866M | $1.2B | $1.5B |
| Long-Term Debt | $34M | $21M | $7M | $253M | $564M |
| Other Non-Current Liab. | $27M | $28M | $34M | $42M | $83M |
| Total Non-Current Liabilities | $81M | $62M | $63M | $320M | $663M |
| Total Liabilities | $737M | $645M | $929M | $1.5B | $2.2B |
| — Equity — | |||||
| Common Stock | $31M | $31M | $31M | $31M | $31M |
| Retained Earnings | $2.0B | $2.2B | $2.6B | $2.8B | $3.2B |
| Accumulated OCI | $21M | $15M | $21M | $21M | $21M |
| Total Stockholders Equity | $2.0B | $2.2B | $2.6B | $2.8B | $3.3B |
| Total Liabilities & Equity | $2.8B | $2.9B | $3.6B | $4.3B | $5.5B |
| — Key Metrics — | |||||
| Total Debt | $300M | $325M | $340M | $732M | $1.1B |
| Net Debt | $294M | $227M | $336M | $673M | $1.1B |
| Total Investments | $315M | $491M | $595M | $607M | $467M |